2-Hydroxy-3-(thiophen-2-yl)pyridine
|
- $155 - $518
- Product name: 2-Hydroxy-3-(thiophen-2-yl)pyridine
- CAS: 30236-48-7
- MF: C9H7NOS
- MW: 177.22
- EINECS:
- MDL Number:MFCD18311917
- Synonyms:2-Hydroxy-3-(thiophen-2-yl)pyridine;2-Hydroxy-3-(2-thienyl)pyridine;2(1H)-Pyridinone, 3-(2-thienyl)-
4 prices
Selected condition：
Brand
- AK Scientific
- Chemenu
- Crysdot
- TRC
Package
- 50mg
- 250mg
- 1g
- ManufacturerAK Scientific
- Product numberV5020
- Product description2-Hydroxy-3-(thiophen-2-yl)pyridine
- Packaging250mg
- Price$344
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM318935
- Product description2-Hydroxy-3-(thiophen-2-yl)pyridine 95%
- Packaging1g
- Price$489
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11150828
- Product description2-Hydroxy-3-(thiophen-2-yl)pyridine 95+%
- Packaging1g
- Price$518
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberH963578
- Product description2-Hydroxy-3-(thiophen-2-yl)pyridine
- Packaging50mg
- Price$155
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | V5020 | 2-Hydroxy-3-(thiophen-2-yl)pyridine | 250mg | $344 | 2021-12-16 | Buy |
| Chemenu | CM318935 | 2-Hydroxy-3-(thiophen-2-yl)pyridine 95% | 1g | $489 | 2021-12-16 | Buy |
| Crysdot | CD11150828 | 2-Hydroxy-3-(thiophen-2-yl)pyridine 95+% | 1g | $518 | 2021-12-16 | Buy |
| TRC | H963578 | 2-Hydroxy-3-(thiophen-2-yl)pyridine | 50mg | $155 | 2021-12-16 | Buy |
Properties
Boiling point :441.6±45.0 °C(Predicted)
Density :1.291±0.06 g/cm3(Predicted)
pka :11.72±0.10(Predicted)
Density :1.291±0.06 g/cm3(Predicted)
pka :11.72±0.10(Predicted)
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|